Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid.

by Samantha Yuille, Nicole Reichardt, Suchita Panda, Hayley Dunbar, Imke E Mulder
Published 2018-01-01

Use of a Preclinical Natural Transmission Model to Study Antiviral Effects of a Carbohydrate-Binding Module Therapy against SARS-CoV-2 in Hamsters

by Daniel Knott, Rachel Fell, Jane A. Potter, Samantha Yuille, Franscisco J. Salguero, Victoria A. Graham, Roger Hewson, David Howat, Stuart D. Dowall
Published 2023-03-01

Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection

by Rachel Fell, Jane A. Potter, Samantha Yuille, Franscisco J. Salguero, Robert Watson, Didier Ngabo, Karen Gooch, Roger Hewson, David Howat, Stuart Dowall
Published 2022-05-01

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

by Maik Luu, Zeno Riester, Adrian Baldrich, Nicole Reichardt, Samantha Yuille, Alessandro Busetti, Matthias Klein, Anne Wempe, Hanna Leister, Hartmann Raifer, Felix Picard, Khalid Muhammad, Kim Ohl, Rossana Romero, Florence Fischer, Christian A. Bauer, Magdalena Huber, Thomas M. Gress, Matthias Lauth, Sophia Danhof, Tobias Bopp, Thomas Nerreter, Imke E. Mulder, Ulrich Steinhoff, Michael Hudecek, Alexander Visekruna
Published 2021-07-01